Assessing Health-related Quality of Life in Patients with Inflammatory Bowel Disease, in Crete, Greece

Overview

Journal BMC Gastroenterol

Publisher Biomed Central

Specialty Gastroenterology

Date 2002 Feb 28

PMID 11866863

Citations 23

Authors

Athanasios G Pallis

Ioannis G Vlachonikolis

Ioannis A Mouzas

Affiliations

Soon will be listed here.

Abstract

Background: Health Related Quality of Life (HRQoL) is an important outcome measure in Inflammatory Bowel Disease (IBD). The aim of our study was to assess HRQoL in a population of 135 Greek patients with IBD.

Methods: A cohort of 135 patients with IBD, 81 with ulcerative colitis (UC) and 54 with Crohn's disease (CD) were enrolled in our study. Demographic and disease-related data were recorded. HRQoL was assessed by a disease-specific and a generic questionnaire, IBDQ and SF-36, respectively. Disease activity was assessed by Harvey-Bradshaw Index and the Colitis Activity Index for CD and UC patients, respectively.

Results: Among all variables recorded in our study, only disease activity had a significant effect on HRQoL. Patients with active disease scored significantly lower on both IBDQ and SF-36 when compared to those in remission. Only two among the four IBDQ dimensions, bowel and systemic, had significant ability in distinguishing best patients in remission from those with active disease.

Conclusions: IBD has a negative impact on HRQoL. Patients with active disease are more impaired than patients in remission. In our population of patients bowel and systemic dimensions had a predominant value in patients' perception of quality of life. Patients in our study using the same instrument scored higher than previously reported.

Citing Articles

The impact of inflammatory bowel diseases on the quality of life of Saudi pediatric patients: A cross-sectional study.

Alhadab A, AlMahamed S, Hassan I, Hammo A Saudi J Gastroenterol. 2022; 28(6):448-455.

PMID: 35946259 PMC: 9843516. DOI: 10.4103/sjg.sjg_162_22.

INFLAMMATORY BOWEL DISEASES: CHARACTERISTICS, EVOLUTION, AND QUALITY OF LIFE.

Mendonca C, Correa Neto I, Rolim A, Robles L Arq Bras Cir Dig. 2022; 35:e1653.

PMID: 35730882 PMC: 9254613. DOI: 10.1590/0102-672020210002e1653.

Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life.

Graff L, Fowler S, Jones J, Benchimol E, Bitton A, Huang J J Can Assoc Gastroenterol. 2021; 4(Suppl 2):S46-S53.

PMID: 34755039 PMC: 8570421. DOI: 10.1093/jcag/gwab031.

Lemann Index for Assessment of Crohn's Disease: Correlation with the Quality of Life, Endoscopic Disease Activity, Magnetic Resonance Index of Activity and C- Reactive Protein.

Straksyte V, Kiudelis G, Gineikiene I, Janciauskas D, Basevicius A, Lukosevicius S Open Med (Wars). 2019; 14:785-791.

PMID: 31737782 PMC: 6843552. DOI: 10.1515/med-2019-0092.

The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life.

Jones J, Nguyen G, Benchimol E, Bernstein C, Bitton A, Kaplan G J Can Assoc Gastroenterol. 2019; 2(Suppl 1):S42-S48.

PMID: 31294384 PMC: 6512247. DOI: 10.1093/jcag/gwy048.

References

Hjortswang H, Strom M, Almer S . Health-related quality of life in Swedish patients with ulcerative colitis. Am J Gastroenterol. 1998; 93(11):2203-11. DOI: 10.1111/j.1572-0241.1998.00537.x. View

Akerkar G, Peppercorn M . Inflammatory bowel disease in the elderly. Practical treatment guidelines. Drugs Aging. 1997; 10(3):199-208. DOI: 10.2165/00002512-199710030-00004. View

Han S, McColl E, Steen N, Barton J, Welfare M . The inflammatory bowel disease questionnaire: a valid and reliable measure in ulcerative colitis patients in the North East of England. Scand J Gastroenterol. 1998; 33(9):961-6. DOI: 10.1080/003655298750026994. View

Irvine E, Zhou Q, Thompson A . The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol. 1996; 91(8):1571-8. View

Garratt A, Ruta D, Abdalla M, Buckingham J, Russell I . The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?. BMJ. 1993; 306(6890):1440-4. PMC: 1677883. DOI: 10.1136/bmj.306.6890.1440. View

Kjeldsen J, Schaffalitzky de Muckadell O . Assessment of disease severity and activity in inflammatory bowel disease. Scand J Gastroenterol. 1993; 28(1):1-9. DOI: 10.3109/00365529309096037. View

Gupta S, Saverymuttu S, Keshavarzian A, Hodgson H . Is the pattern of inflammatory bowel disease different in the elderly?. Age Ageing. 1985; 14(6):366-70. DOI: 10.1093/ageing/14.6.366. View

Irvine E . Quality of Life--rationale and methods for developing a disease-specific instrument for inflammatory bowel disease. Scand J Gastroenterol Suppl. 1993; 199:22-7. DOI: 10.3109/00365529309098351. View

Martin A, Leone L, Fries W, Naccarato R . Quality of life in inflammatory bowel disease. Ital J Gastroenterol. 1995; 27(8):450-4. View

10.

McMahon A, Schmitt P, PATTERSON J, Rothman E . Personality differences between inflammatory bowel disease patients and their healthy siblings. Psychosom Med. 1973; 35(2):91-103. DOI: 10.1097/00006842-197303000-00001. View

11.

Irvine E, Feagan B, Rochon J, Archambault A, Fedorak R, Groll A . Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology. 1994; 106(2):287-96. DOI: 10.1016/0016-5085(94)90585-1. View

12.

Lichtiger S, Present D, Kornbluth A, Gelernt I, Bauer J, Galler G . Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994; 330(26):1841-5. DOI: 10.1056/NEJM199406303302601. View

13.

McHorney C, Ware Jr J, Lu J, Sherbourne C . The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994; 32(1):40-66. DOI: 10.1097/00005650-199401000-00004. View

14.

Brazier J, Harper R, Jones N, OCathain A, Thomas K, Usherwood T . Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992; 305(6846):160-4. PMC: 1883187. DOI: 10.1136/bmj.305.6846.160. View

15.

Fraga X, Vergara M, Medina C, Casellas F, Bermejo B, Malagelada J . Effects of smoking on the presentation and clinical course of inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1997; 9(7):683-7. DOI: 10.1097/00042737-199707000-00007. View

16.

Guyatt G, Mitchell A, Irvine E, Singer J, Williams N, Goodacre R . A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989; 96(3):804-10. View

17.

Harvey R, Bradshaw J . A simple index of Crohn's-disease activity. Lancet. 1980; 1(8167):514. DOI: 10.1016/s0140-6736(80)92767-1. View

18.

Joachim G, Milne B . The effects of inflammatory bowel disease on lifestyle. Can Nurse. 1985; 81(10):38-40. View

19.

Kim W, Cho Y, Yoo H, Park I, Park E, Lim J . Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behçet's disease. Int J Colorectal Dis. 1999; 14(1):52-7. DOI: 10.1007/s003840050183. View

20.

Logan R, Edmond M, Somerville K, Langman M . Smoking and ulcerative colitis. Br Med J (Clin Res Ed). 1984; 288(6419):751-3. PMC: 1444645. DOI: 10.1136/bmj.288.6419.751. View